NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

動物用疫苗的全球市場:各產品,各動物種類的預測(到2025年)- COVID-19累積的影響

Animal Vaccines Market Research Report by Product, by Animal Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1002738
出版日期 內容資訊 英文 194 Pages
商品交期: 最快1-2個工作天內
價格
動物用疫苗的全球市場:各產品,各動物種類的預測(到2025年)- COVID-19累積的影響 Animal Vaccines Market Research Report by Product, by Animal Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 194 Pages
簡介

全球動物用疫苗的市場規模預計將從2020年的129億8,256萬美元擴大到2025年的185億3,357萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

本報告提供全球動物用疫苗市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,產品·動物的種類·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查方法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查的成果

第3章 摘要整理

  • 市場展望
  • 各動物類型市場展望
  • 各產品市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 搬運工人的aibufosu分析

第6章 全球動物用疫苗市場,各產品

  • 減毒活病毒疫苗
  • DNA疫苗
  • 不活化疫苗
  • 重組疫苗
  • 次單元疫苗

第7章 各動物類型市場

  • 水產養殖
    • 產氣單胞桿菌
    • 鏈球菌病
    • 弧菌屬
  • 伴同性
  • 家禽
    • 禽流感
    • 傳染性支氣管炎
    • 馬立克氏病
    • 新城病
    • 沙門氏菌
  • 反芻動物
    • 冠狀病毒
    • 大腸菌
    • 口蹄疫(FMD)
    • Lumpy skin
    • 輪狀病毒

第8章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東·非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併·收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第12章 企業簡介

  • Anicon Labor GmbH
  • Biogenesis Bago S.A.
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • CEVA Inc
  • China Animal Husbandry Industry Co., Ltd.
  • Elanco LLC
  • Endovac Animal Health, LLC
  • Heska Corporation
  • Hester Biosciences Limited
  • HIPRA SA
  • Indian Immunologicals Limited
  • Jinyu Bio-Technology Co., Ltd.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Phibro Animal Health Corporation
  • Sanofi S.A.
  • Torigen Pharmaceuticals Inc
  • Vaxxinova GmbH
  • VEROVACCiNES GmbH
  • Vetoquinol SA
  • Virbac, Inc.
  • Zoetis Inc.

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-ED54C46E8F17

The Global Animal Vaccines Market size was estimated at USD 12.98 Billion in 2020 and expected to reach USD 14.00 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.21% to reach USD 20.85 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Animal Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product , the Animal Vaccines Market was studied across Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines.

Based on Animal Type , the Animal Vaccines Market was studied across Aqua, Companion, Poultry, and Ruminants. The Aqua is further studied across Aeromonas, Streptococcosis, and Vibrio. The Companion is further studied across Canine and Feline. The Poultry is further studied across Avian Influenza, Infectious Bronchitis, Marek's Disease, Newcastle Disease, and Salmonella. The Ruminants is further studied across Coronavirus, E. Coli, Foot & mouth disease (FMD), Lumpy skin, and Rotavirus.

Based on Geography, the Animal Vaccines Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Vaccines Market, including Anicon Labor GmbH, Biogenesis Bago S.A., Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, CEVA Inc, China Animal Husbandry Industry Co., Ltd., Elanco LLC, Endovac Animal Health, LLC, Heska Corporation, Hester Biosciences Limited, HIPRA SA, Indian Immunologicals Limited, Jinyu Bio-Technology Co., Ltd., Merck & Co., Inc., Neogen Corporation, Phibro Animal Health Corporation, Phibro Animal Health Corporation, Sanofi S.A., Torigen Pharmaceuticals Inc, Vaxxinova GmbH, VEROVACCiNES GmbH, Vetoquinol SA, Virbac, Inc., and Zoetis Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Animal Vaccines Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Vaccines Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Vaccines Market?
  • 4. What is the competitive strategic window for opportunities in the Global Animal Vaccines Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Animal Vaccines Market?
  • 6. What is the market share of the leading vendors in the Global Animal Vaccines Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Animal Vaccines Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Animal Type Outlook
  • 3.4. Product Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing livestock population
      • 5.1.1.2. Rising animal husbandry along with commercialization of animal products
      • 5.1.1.3. Increasing incidences of zoonotic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High Storage cost of vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Shift from live attenuated vaccines to DNA vaccines
      • 5.1.3.2. Continuous technology advancements in vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse impacts of vaccines
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Animal Vaccines Market, by Product

  • 6.1. Introduction
  • 6.2. Attenuated Live Vaccines
  • 6.3. DNA Vaccines
  • 6.4. Inactivated Vaccines
  • 6.5. Recombinant Vaccines
  • 6.6. Subunit Vaccines

7. Animal Vaccines Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Aqua
    • 7.2.1. Aeromonas
    • 7.2.2. Streptococcosis
    • 7.2.3. Vibrio
  • 7.3. Companion
    • 7.3.1. Canine
      • 7.3.1.1. Canine Herpes
      • 7.3.1.2. Distemper
      • 7.3.1.3. Kennel Cough
      • 7.3.1.4. Lyme Disease
      • 7.3.1.5. Parvovirus
      • 7.3.1.6. Rabies
    • 7.3.2. Feline
      • 7.3.2.1. Calicivirus
      • 7.3.2.2. Coronavirus
      • 7.3.2.3. Panleukopenia
      • 7.3.2.4. Rabies
      • 7.3.2.5. Rhinotracheitis
  • 7.4. Poultry
    • 7.4.1. Avian Influenza
    • 7.4.2. Infectious Bronchitis
    • 7.4.3. Marek's Disease
    • 7.4.4. Newcastle Disease
    • 7.4.5. Salmonella
  • 7.5. Ruminants
    • 7.5.1. Coronavirus
    • 7.5.2. E. Coli
    • 7.5.3. Foot & mouth disease (FMD)
    • 7.5.4. Lumpy skin
    • 7.5.5. Rotavirus

8. Americas Animal Vaccines Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Animal Vaccines Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Animal Vaccines Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Anicon Labor GmbH
  • 12.2. Biogenesis Bago S.A.
  • 12.3. Boehringer Ingelheim International GmbH
  • 12.4. Brilliant Bio Pharma Private Limited
  • 12.5. CEVA Inc
  • 12.6. China Animal Husbandry Industry Co., Ltd.
  • 12.7. Elanco LLC
  • 12.8. Endovac Animal Health, LLC
  • 12.9. Heska Corporation
  • 12.10. Hester Biosciences Limited
  • 12.11. HIPRA SA
  • 12.12. Indian Immunologicals Limited
  • 12.13. Jinyu Bio-Technology Co., Ltd.
  • 12.14. Merck & Co., Inc.
  • 12.15. Neogen Corporation
  • 12.16. Phibro Animal Health Corporation
  • 12.17. Phibro Animal Health Corporation
  • 12.18. Sanofi S.A.
  • 12.19. Torigen Pharmaceuticals Inc
  • 12.20. Vaxxinova GmbH
  • 12.21. VEROVACCiNES GmbH
  • 12.22. Vetoquinol SA
  • 12.23. Virbac, Inc.
  • 12.24. Zoetis Inc.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL VACCINES MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2020 (USD BILLION)
  • FIGURE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2020 (USD BILLION)
  • FIGURE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL ANIMAL VACCINES MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL ANIMAL VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2026
  • FIGURE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2020 VS 2026 (USD BILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2026
  • FIGURE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, 2018-2026 (USD BILLION)
  • FIGURE 26. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, 2018-2026 (USD BILLION)
  • FIGURE 28. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, 2018-2026 (USD BILLION)
  • FIGURE 38. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, 2018-2026 (USD BILLION)
  • FIGURE 40. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, 2018-2026 (USD BILLION)
  • FIGURE 42. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, 2018-2026 (USD BILLION)
  • FIGURE 44. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, 2018-2026 (USD BILLION)
  • FIGURE 46. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2026 (USD BILLION)
  • FIGURE 48. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 49. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, 2018-2026 (USD BILLION)
  • FIGURE 50. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 51. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, 2018-2026 (USD BILLION)
  • FIGURE 52. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 53. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, 2018-2026 (USD BILLION)
  • FIGURE 54. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 55. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, 2018-2026 (USD BILLION)
  • FIGURE 56. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 57. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, 2018-2026 (USD BILLION)
  • FIGURE 58. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 59. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2026 (USD BILLION)
  • FIGURE 60. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 61. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, 2018-2026 (USD BILLION)
  • FIGURE 62. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 63. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, 2018-2026 (USD BILLION)
  • FIGURE 64. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 65. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, 2018-2026 (USD BILLION)
  • FIGURE 66. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 67. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, 2018-2026 (USD BILLION)
  • FIGURE 68. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 69. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, 2018-2026 (USD BILLION)
  • FIGURE 70. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 71. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2026 (USD BILLION)
  • FIGURE 72. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 73. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, 2018-2026 (USD BILLION)
  • FIGURE 74. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 75. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, 2018-2026 (USD BILLION)
  • FIGURE 76. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 77. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), 2018-2026 (USD BILLION)
  • FIGURE 78. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 79. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, 2018-2026 (USD BILLION)
  • FIGURE 80. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 81. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, 2018-2026 (USD BILLION)
  • FIGURE 82. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 83. AMERICAS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 84. AMERICAS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 85. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 86. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 87. BRAZIL ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 88. CANADA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 89. MEXICO ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 90. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 91. CALIFORNIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 92. FLORIDA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 93. ILLINOIS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 94. NEW YORK ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 95. OHIO ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 96. PENNSYLVANIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 97. TEXAS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 98. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 99. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 100. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 101. CHINA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 102. INDIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 103. INDONESIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 104. JAPAN ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 105. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 106. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 107. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 108. THAILAND ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 109. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 110. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 111. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 112. FRANCE ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 113. GERMANY ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 114. ITALY ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 115. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 116. QATAR ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 117. RUSSIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 118. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 119. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 120. SPAIN ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 121. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 122. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 123. GLOBAL ANIMAL VACCINES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 124. GLOBAL ANIMAL VACCINES MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 125. GLOBAL ANIMAL VACCINES MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 126. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANIMAL VACCINES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. AMERICAS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. AMERICAS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. AMERICAS ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. CANADA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. CANADA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. MEXICO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. MEXICO ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. CALIFORNIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. CALIFORNIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. FLORIDA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. FLORIDA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. ILLINOIS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. ILLINOIS ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. NEW YORK ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. NEW YORK ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. OHIO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. OHIO ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. PENNSYLVANIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. PENNSYLVANIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. TEXAS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. TEXAS ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. CHINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. CHINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. INDIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. INDIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. INDONESIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. INDONESIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. JAPAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. JAPAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. THAILAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. THAILAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. FRANCE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. FRANCE ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. GERMANY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. GERMANY ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. ITALY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. ITALY ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. QATAR ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. QATAR ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. SPAIN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. SPAIN ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. GLOBAL ANIMAL VACCINES MARKET: SCORES
  • TABLE 113. GLOBAL ANIMAL VACCINES MARKET: BUSINESS STRATEGY
  • TABLE 114. GLOBAL ANIMAL VACCINES MARKET: PRODUCT SATISFACTION
  • TABLE 115. GLOBAL ANIMAL VACCINES MARKET: RANKING
  • TABLE 116. GLOBAL ANIMAL VACCINES MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 117. GLOBAL ANIMAL VACCINES MARKET: SHARE, BY COMPANY, 2020
  • TABLE 118. GLOBAL ANIMAL VACCINES MARKET: MERGER & ACQUISITION
  • TABLE 119. GLOBAL ANIMAL VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 120. GLOBAL ANIMAL VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 121. GLOBAL ANIMAL VACCINES MARKET: INVESTMENT & FUNDING
  • TABLE 122. GLOBAL ANIMAL VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 123. GLOBAL ANIMAL VACCINES MARKET: LICENSE & PRICING
  • TABLE 124. GLOBAL ANIMAL VACCINES MARKET: CONTACT DETAILS